Clinical Features, Treatment Outcome and Potential risk Factors for Recurrence Among Patients with Chronic Pulmonary Aspergillosis in a Resource–limited Setting: A Retrospective Observational Study-Reference-Cited by-同舟云学术

Clinical Features, Treatment Outcome and Potential risk Factors for Recurrence Among Patients with Chronic Pulmonary Aspergillosis in a Resource–limited Setting: A Retrospective Observational Study

Published:2024-08-22 Issue:5 Volume:189 Page:
ISSN:0301-486X
Container-title:Mycopathologia
language:en
Short-container-title:Mycopathologia

Author:

Aksoy Emine^ORCID,Yildirim Elif,Ozmen Ipek,Yilmaz Nermin Ozer,Karaman Ahmet Kursat,Takir Huriye,Ozbaki Fatma,Agca Meltem,Berk Aysegul

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11046-024-00884-9.pdf

Reference47 articles.

1. Alastruey–Izquierdo A, Cadranel J, Flick H, Godet C, Hennequin C, Hoenigl M, et al. on behalf of CPAnet Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives. Respiration. 2018;96(2):159–70. https://doi.org/10.1159/000489474.

2. Denning DW, Cadranel J, Beigelman–Aubry C, Ader F, Chakrabarti A, Blot S, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis andmanagement. Eur Respir J. 2016;47(1):45–68. https://doi.org/10.1183/13993003.00583-2015.

3. Hilmioğlu–Polat S, Seyedmousavi S, Ilkit M, Hedayati MT, Inci R, Tumbay E, et al. Estimated burden of serious human fungal diseases in Turkey. Mycoses. 2019;62(1):22–31. https://doi.org/10.1111/myc.12842.

4. Kanj A, Abdallah N, Soubani AO. The spectrum of pulmonary aspergillosis. Respir Med. 2018;141:121–31. https://doi.org/10.1016/j.rmed.2018.06.029.

5. Niu Y, Li J, Shui W, Li D, Yu C, Fu X, et al. Clinical features and outcome of patients with chronic pulmonary aspergillosis in China: A retrospective, observational study. J Mycol Med. 2020;30(4): 101041. https://doi.org/10.1016/j.mycmed.2020.101041.